ITEM 2.02-RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2022 and forward-looking statements relating to 2022 and beyond as presented in a press release dated January 31, 2023.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

ITEM 9.01-FINANCIAL STATEMENTS AND EXHIBITS

The following is filed as an exhibit to this report:





 Exhibit
 Number*                        Title of Document                         Location
Item 99.1   Financial information for Utah Medical Products, Inc. for
            the three and twelve months ended December 31, 2022 and
            forward-looking statements relating to 2022 and beyond as
            presented in a press release dated January 31, 2023.
                                                                         This filing

_______________________________________

*All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.

© Edgar Online, source Glimpses